Related Experiment Video
Updated: Jul 19, 2026

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Published on: March 24, 2023
Caspase-3 mediated feedback activation of apical caspases in doxorubicin and TNF-alpha induced apoptosis
Shihe Yang1, Ann D Thor, Susan Edgerton
1Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Abstract:
Aberrant apoptosis has been associated with the development and therapeutic resistance of cancer. Recent studies suggest that caspase deficiency/downregulation is frequently detected in different cancers. We have previously shown that caspase-3 reconstitution significantly sensitized MCF-7 cells to doxorubicin and etoposide. In contrast to the well established role of caspase-3 as an effector caspase, the focus of this study is to delineate caspase-3 induced feedback activation of the apical caspases-2, -8, -9 and -10A in doxorubicin and TNF-alpha induced apoptosis. Using cell-free systems we show that caspases-9 and 2 are the most sensitive, caspase-8 is less sensitive and caspase-10A is the least sensitive to caspase-3 mediated-cleavage. When apoptosis is induced by doxorubicin or TNF-alpha in an intact cell model, cleavage of caspases-8 and -9, but not caspase-2, was markedly enhanced by caspase-3. Caspase-3 mediated-feedback and activation of caspase-8 and -9 in MCF-7/C3 cells is further supported by an increase in the cleavage of caspase-8 and 9 substrates and cytochrome c release. These data indicate that, in addition to its function as an effector caspase, caspase-3 plays an important role in maximizing the activation of apical caspases and crosstalk between the two major apoptotic pathways. The significant impact of caspase-3 on both effector and apical caspases suggests that modulation of caspase-3 activity would be a useful approach to overcome drug resistance in clinical oncology.
Insights
Caspase-3, an effector caspase, also activates apical caspases (caspase-2, -8, -9, -10A) during apoptosis. This feedback loop enhances cancer cell death and may overcome drug resistance.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Aberrant apoptosis is linked to cancer development and therapeutic resistance.
- Caspase deficiency is common in various cancers.
- Caspase-3 reconstitution sensitizes cancer cells to chemotherapy.
Purpose of the Study:
- To investigate caspase-3's role in feedback activation of apical caspases (caspase-2, -8, -9, -10A).
- To understand caspase-3's impact on doxorubicin and TNF-alpha induced apoptosis.
- To explore the crosstalk between effector and apical caspases.
Main Methods:
- Cell-free systems to assess caspase-3 mediated cleavage sensitivity.
- Intact cell models (MCF-7/C3) to study apoptosis induction.
- Analysis of caspase cleavage, substrate cleavage, and cytochrome c release.
Main Results:
- Caspase-3 efficiently cleaves caspases-9 and -2 in cell-free systems.
- In intact cells, caspase-3 enhances cleavage of caspases-8 and -9, but not caspase-2.
- Caspase-3 mediated feedback increases substrate cleavage and cytochrome c release, indicating enhanced apoptosis.
Conclusions:
- Caspase-3 acts as an effector caspase and also amplifies apical caspase activation.
- Caspase-3 plays a crucial role in crosstalk between apoptotic pathways.
- Modulating caspase-3 activity could be a strategy to overcome cancer drug resistance.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...

